Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oligosaccharide-protein conjugates.

Eitemau Tebyg

• Minimal oligosaccharide structures required for induction of immune responses against meningococcal immunotype L1, L2, and L3,7,9 lipopolysaccharides determined by using synthetic oligosaccharide-protein conjugates.
  gan: Verheul, A F, et al.
  Cyhoeddwyd: (1991)
• Development, characterization, and biological properties of meningococcal immunotype L3,7,(8),9-specific monoclonal antibodies.
  gan: Verheul, A F, et al.
  Cyhoeddwyd: (1994)
• Meningococcal lipopolysaccharide (LPS)-derived oligosaccharide-protein conjugates evoke outer membrane protein- but not LPS-specific bactericidal antibodies in mice: influence of adjuvants.
  gan: Verheul, A F, et al.
  Cyhoeddwyd: (1993)
• Preparation, characterization, and immunogenicity of meningococcal lipooligosaccharide-derived oligosaccharide-protein conjugates.
  gan: Gu, X X, et al.
  Cyhoeddwyd: (1993)
• Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.
  gan: Verheul, A F, et al.
  Cyhoeddwyd: (1993)